Publicaciones en las que colabora con Javier Zulueta Frances (111)

2024

  1. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564

  2. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  3. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

    Journal of Thoracic Oncology, Vol. 19, Núm. 3, pp. 476-490

  4. The tip of the iceberg: a plethora of lung nodules in the general population

    The European respiratory journal

  5. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)

    Radiology, Vol. 309, Núm. 2, pp. e231988

  2. Circulating proteome for pulmonary nodule malignancy

    Journal of the National Cancer Institute, Vol. 115, Núm. 9, pp. 1060-1070

  3. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

2022

  1. Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection

    Cells, Vol. 11, Núm. 12

  2. New or enlarging hiatal hernias after thoracic surgery for early lung cancer

    JTCVS Open, Vol. 10, pp. 415-423

2021

  1. A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer

    Translational Research, Vol. 233, pp. 77-91

  2. Chronic rhinosinusitis is associated with prolonged SARS-CoV-2 RNA shedding in upper respiratory tract samples: A case-control study

    Journal of Internal Medicine, Vol. 289, Núm. 6, pp. 921-925

  3. Diagnostic accuracy of visual analysis versus dual time-point imaging with 18F-FDG PET/CT for the characterization of indeterminate pulmonary nodules with low uptake

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 3, pp. 155-160

  4. Early adherence to lung cancer screening

    Annals of the American Thoracic Society

  5. Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial

    ERJ Open Research, Vol. 7, Núm. 2, pp. 00773-2020

  6. Lung cancer risk among patients with asthma–chronic obstructive pulmonary disease overlap

    Annals of the American Thoracic Society, Vol. 18, Núm. 11, pp. 1894-1900

  7. Molecular biomarkers in early stage lung cancer

    Translational Lung Cancer Research, Vol. 10, Núm. 2, pp. 1165-1185

  8. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

  9. Notch3 deficiency attenuates pulmonary fibrosis and impedes lung-function decline

    American Journal of Respiratory Cell and Molecular Biology, Vol. 64, Núm. 4, pp. 465-476

  10. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD

    Clinical Imaging, Vol. 78, pp. 136-141